{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:51:15Z","timestamp":1762325475653,"version":"3.37.3"},"reference-count":12,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Support Palliat Care"],"accepted":{"date-parts":[[2022,10,28]]},"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>To detail important lessons learnt while conducting several large, medicinal cannabis (MC) randomised clinical trials in a palliative cancer population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Investigators involved in these trials had several meetings to agree on the major lessons learnt and how the various challenges could be mitigated in the future.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The lessons were sorted into separate categories: patient confidentiality, family dynamics, driving, cost, unfounded beliefs, accessing specific MC products, trial funding, telehealth and COVID-19, and miscellaneous issues.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Using MC as the intervention arm in such trials entails some unique regulatory, logistical and other challenges. This short report presents key lessons learnt in conducting these randomised controlled trials in a palliative care population for the benefit of future investigators planning similar trials in a similar patient population.<\/jats:p><\/jats:sec>","DOI":"10.1136\/spcare-2022-004035","type":"journal-article","created":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T18:20:19Z","timestamp":1668536419000},"page":"238-240","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Medicinal cannabis in palliative medicine: lessons learnt from randomised controlled trials"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9695-9109","authenticated-orcid":false,"given":"Taylan","family":"Gurgenci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Olson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgie","family":"Huggett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7525-1547","authenticated-orcid":false,"given":"Karyn","family":"Foster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8198-0375","authenticated-orcid":false,"given":"Phillip","family":"Good","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,11,15]]},"reference":[{"key":"2024051713141745000_13.2.238.1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.31128\/AJGP-02-21-5831","article-title":"Medicinal cannabis use in palliative care","volume":"50","author":"Herbert","year":"2021","journal-title":"Aust J Gen Pract"},{"key":"2024051713141745000_13.2.238.2","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12904-019-0494-6","article-title":"Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD)","volume":"18","author":"Good","year":"2019","journal-title":"BMC Palliat Care"},{"key":"2024051713141745000_13.2.238.3","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1186\/s13063-020-04541-6","article-title":"Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)","volume":"21","author":"Hardy","year":"2020","journal-title":"Trials"},{"key":"2024051713141745000_13.2.238.4","first-page":"1","article-title":"The analysis of cannabinoids in biological fluids","volume":"42","year":"1982","journal-title":"NIDA Res Monogr"},{"key":"2024051713141745000_13.2.238.5","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/dta.1514","article-title":"Current knowledge on cannabinoids in oral fluid","volume":"6","author":"Lee","year":"2014","journal-title":"Drug Test Anal"},{"key":"2024051713141745000_13.2.238.6","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2011.169490"},{"key":"2024051713141745000_13.2.238.7","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/dta.2092","article-title":"Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administration","volume":"9","author":"Swortwood","year":"2017","journal-title":"Drug Test Anal"},{"key":"2024051713141745000_13.2.238.8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.31128\/AJGP-02-21-5845","article-title":"A primer on medicinal cannabis safety and potential adverse effects","volume":"50","author":"Arnold","year":"2021","journal-title":"Aust J Gen Pract"},{"key":"2024051713141745000_13.2.238.9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.01.187"},{"key":"2024051713141745000_13.2.238.10","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/imj.13224","article-title":"Clinical trials of medicinal cannabis for appetite-related symptoms from advanced cancer: a survey of preferences, attitudes and beliefs among patients willing to consider participation","volume":"46","author":"Luckett","year":"2016","journal-title":"Intern Med J"},{"key":"2024051713141745000_13.2.238.11","doi-asserted-by":"publisher","DOI":"10.1177\/026921639701100514"},{"key":"2024051713141745000_13.2.238.12","doi-asserted-by":"publisher","DOI":"10.1177\/026921639701100611"}],"container-title":["BMJ Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/spcare-2022-004035","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T22:50:41Z","timestamp":1715986241000},"score":1,"resource":{"primary":{"URL":"https:\/\/spcare.bmj.com\/lookup\/doi\/10.1136\/spcare-2022-004035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,15]]},"references-count":12,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,5,18]]},"published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10.1136\/spcare-2022-004035"],"URL":"https:\/\/doi.org\/10.1136\/spcare-2022-004035","relation":{},"ISSN":["2045-435X","2045-4368"],"issn-type":[{"type":"print","value":"2045-435X"},{"type":"electronic","value":"2045-4368"}],"subject":[],"published":{"date-parts":[[2022,11,15]]}}}